Literature DB >> 22202553

Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer.

Hari Trivedi1, Baris Turkbey, Ardeshir R Rastinehad, Compton J Benjamin, Marcelino Bernardo, Thomas Pohida, Vijay Shah, Maria J Merino, Bradford J Wood, W Marston Linehan, Aradhana M Venkatesan, Peter L Choyke, Peter A Pinto.   

Abstract

OBJECTIVE: To demonstrate the use of a patient-specific magnetic resonance imaging (MRI)-based prostate mold to generate histologic sections that directly correlate to axial MRI slices in a patient with anteriorly located prostate cancer. Anteriorly located prostate cancer has traditionally been difficult to detect on digital rectal examination and transrectal ultrasound-guided biopsy. Multiparametric MRI has potential as a valuable tool for the diagnosis and focal treatment of prostate cancer. A significant difficulty to date has been accurate correlation between the magnetic resonance images and histopathologic specimens.
METHODS: A patient-specific mold from a preoperative T2-weighted MRI scan was created to hold and shape the prostate specimen. Slots for slicing were positioned at 6-mm increments coplanar to the axial MRI slices. After surgical excision, the specimen was inked to maintain the orientation and fixed in formalin. The seminal vesicles were excised, and the prostate was oriented in the mold such that the color-coding matched the anatomic labels on the mold. The specimen was sliced with a single blade and the resultant 6-mm tissue blocks were used for histologic analysis.
RESULTS: Preoperative multiparametric MRI revealed a lesion in the right anterior transition zone that was positive on T2-weighed MRI, apparent diffusion coefficient maps of diffusion-weighted MRI, magnetic resonance spectroscopy, and dynamic contrast-enhanced MRI. The histologic sections obtained using the mold demonstrated a similar Gleason score 6 (3+3) lesion in the right anterior transition zone, correlating with the MRI findings.
CONCLUSION: The use of patient-specific prostate molds to register the MRI findings with the histopathologic specimen in prostate cancer could offer several benefits compared with current specimen processing techniques. This technique might further validate MRI as an accurate tool for prostate cancer localization and staging.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22202553      PMCID: PMC3534884          DOI: 10.1016/j.urology.2011.10.002

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  21 in total

1.  Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.

Authors:  Stefan A Reinsberg; Geoffrey S Payne; Sophie F Riches; Sue Ashley; Jonathan M Brewster; Veronica A Morgan; Nandita M deSouza
Journal:  AJR Am J Roentgenol       Date:  2007-01       Impact factor: 3.959

2.  A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds.

Authors:  Vijay Shah; Thomas Pohida; Baris Turkbey; Haresh Mani; Maria Merino; Peter A Pinto; Peter Choyke; Marcelino Bernardo
Journal:  Rev Sci Instrum       Date:  2009-10       Impact factor: 1.523

Review 3.  Optimum slicing of radical prostatectomy specimens for correlation between histopathology and medical images.

Authors:  Li Hong Chen; Henry Ho; Richie Lazaro; Choon Hua Thng; John Yuen; Wan Sing Ng; Chris Cheng
Journal:  Int J Comput Assist Radiol Surg       Date:  2010-02-24       Impact factor: 2.924

4.  Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation.

Authors:  Baris Turkbey; Peter A Pinto; Haresh Mani; Marcelino Bernardo; Yuxi Pang; Yolanda L McKinney; Kiranpreet Khurana; Gregory C Ravizzini; Paul S Albert; Maria J Merino; Peter L Choyke
Journal:  Radiology       Date:  2010-04       Impact factor: 11.105

5.  Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging.

Authors:  Huadong Miao; Hiroshi Fukatsu; Takeo Ishigaki
Journal:  Eur J Radiol       Date:  2006-11-07       Impact factor: 3.528

Review 6.  Functional MR imaging of prostate cancer.

Authors:  Young Jun Choi; Jeong Kon Kim; Namkug Kim; Kyoung Won Kim; Eugene K Choi; Kyoung-Sik Cho
Journal:  Radiographics       Date:  2007 Jan-Feb       Impact factor: 5.333

7.  Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies.

Authors:  Sheng Xu; Jochen Kruecker; Baris Turkbey; Neil Glossop; Anurag K Singh; Peter Choyke; Peter Pinto; Bradford J Wood
Journal:  Comput Aided Surg       Date:  2008-09

Review 8.  Imaging techniques for prostate cancer: implications for focal therapy.

Authors:  Baris Turkbey; Peter A Pinto; Peter L Choyke
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

9.  Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance.

Authors:  Stijn W T P J Heijmink; Jurgen J Fütterer; Thomas Hambrock; Satoru Takahashi; Tom W J Scheenen; Henkjan J Huisman; Christina A Hulsbergen-Van de Kaa; Ben C Knipscheer; Lambertus A L M Kiemeney; J Alfred Witjes; Jelle O Barentsz
Journal:  Radiology       Date:  2007-05-10       Impact factor: 11.105

10.  Dynamic contrast-enhanced MRI for prostate cancer localization.

Authors:  A S N Jackson; S A Reinsberg; S A Sohaib; E M Charles-Edwards; S Jhavar; T J Christmas; A C Thompson; M J Bailey; C M Corbishley; C Fisher; M O Leach; D P Dearnaley
Journal:  Br J Radiol       Date:  2009-02       Impact factor: 3.039

View more
  36 in total

1.  Preliminary experience with a novel method of three-dimensional co-registration of prostate cancer digital histology and in vivo multiparametric MRI.

Authors:  C Orczyk; H Rusinek; A B Rosenkrantz; A Mikheev; F-M Deng; J Melamed; S S Taneja
Journal:  Clin Radiol       Date:  2013-08-28       Impact factor: 2.350

2.  Quantitative identification of magnetic resonance imaging features of prostate cancer response following laser ablation and radical prostatectomy.

Authors:  Geert J S Litjens; Henkjan J Huisman; Robin M Elliott; Natalie Nc Shih; Michael D Feldman; Satish Viswanath; Jurgen J Fütterer; Joyce G R Bomers; Anant Madabhushi
Journal:  J Med Imaging (Bellingham)       Date:  2014-10-27

3.  A system for evaluating magnetic resonance imaging of prostate cancer using patient-specific 3D printed molds.

Authors:  Alan Priester; Shyam Natarajan; Jesse D Le; James Garritano; Bryan Radosavcev; Warren Grundfest; Daniel Ja Margolis; Leonard S Marks; Jiaoti Huang
Journal:  Am J Clin Exp Urol       Date:  2014-07-12

Review 4.  Imaging modalities in focal therapy: patient selection, treatment guidance, and follow-up.

Authors:  Berrend G Muller; Willemien van den Bos; Peter A Pinto; Jean J de la Rosette
Journal:  Curr Opin Urol       Date:  2014-05       Impact factor: 2.309

5.  Imaging of prostate cancer: a platform for 3D co-registration of in-vivo MRI ex-vivo MRI and pathology.

Authors:  Clement Orczyk; Artem Mikheev; Andrew B Rosenkrantz; Jonathan Melamed; Samir S Taneja; Henry Rusinek
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2012-02-23

6.  Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation.

Authors:  Fiona M Fennessy; Andriy Fedorov; Tobias Penzkofer; Kyung Won Kim; Michelle S Hirsch; Mark G Vangel; Paul Masry; Trevor A Flood; Ming-Ching Chang; Clare M Tempany; Robert V Mulkern; Sandeep N Gupta
Journal:  Magn Reson Imaging       Date:  2015-02-14       Impact factor: 2.546

7.  Characteristics of Detected and Missed Prostate Cancer Foci on 3-T Multiparametric MRI Using an Endorectal Coil Correlated With Whole-Mount Thin-Section Histopathology.

Authors:  Nelly Tan; Daniel J Margolis; David Y Lu; Kevin G King; Jiaoti Huang; Robert E Reiter; Steven S Raman
Journal:  AJR Am J Roentgenol       Date:  2015-07       Impact factor: 3.959

Review 8.  Prostate cancer detection and diagnosis: the role of MR and its comparison with other diagnostic modalities--a radiologist's perspective.

Authors:  Tobias Penzkofer; Clare M Tempany-Afdhal
Journal:  NMR Biomed       Date:  2013-09-03       Impact factor: 4.044

9.  Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: correlation with tumor cell density and percentage Gleason pattern on whole mount pathology.

Authors:  Daniel I Glazer; Elmira Hassanzadeh; Andriy Fedorov; Olutayo I Olubiyi; Shayna S Goldberger; Tobias Penzkofer; Trevor A Flood; Paul Masry; Robert V Mulkern; Michelle S Hirsch; Clare M Tempany; Fiona M Fennessy
Journal:  Abdom Radiol (NY)       Date:  2017-03

10.  Magnetic resonance imaging (MRI)-guided transurethral ultrasound therapy of the prostate: a preclinical study with radiological and pathological correlation using customised MRI-based moulds.

Authors:  Ari Partanen; Nitin K Yerram; Hari Trivedi; Matthew R Dreher; Juha Oila; Anthony N Hoang; Dmitry Volkin; Jeffrey Nix; Baris Turkbey; Marcelino Bernardo; Diana C Haines; Compton J Benjamin; W Marston Linehan; Peter Choyke; Bradford J Wood; Gösta J Ehnholm; Aradhana M Venkatesan; Peter A Pinto
Journal:  BJU Int       Date:  2013-06-07       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.